Democrats are expressing concern over Troy Jackson, a leading candidate for the Democratic Senate nomination in Maine, following a recent debate performance that highlighted worries about his readiness for a general election contest against Republican incumbent Susan Collins.
During a debate, Jackson's response to a question on oversight veered into a discussion about prescription drug costs and healthcare. "As far as something like this, prescription drugs. I mean, I live around the border. I see people in New Brunswick that are going with healthcare, they’re going with prescription drugs, the same drugs that we have, and nobody in D.C. is actually doing anything because the healthcare industry, big pharma, is buying them out and we can’t afford to buy them back," Jackson stated.
While other candidates on the debate stage offered more polished responses, Jackson is positioned to become the Democratic nominee in Maine, a state that represents one of the party's most viable opportunities to unseat a Republican senator this fall. Susan Collins, who has served five terms, is the only Republican incumbent running in a state that voted for President Biden in the last election. She has seen a decline in support among Maine's Democrats and independents.
Senate Democrats had initially hoped to recruit Governor Janet Mills for the race. However, Mills withdrew her bid before Graham Platner, another potential candidate, was forced out of the running after facing an allegation of rape from an ex-girlfriend, which he denies. The subsequent scramble to replace Platner led to Jackson, a former Republican and logger who previously ran for Governor and secured third place, emerging as the preferred choice.
The alignment of Jackson's ideology with the party's goals, coupled with his current political standing, has led to a nomination process that some within the Democratic party view with apprehension, particularly in light of his recent debate performance.